News

Bakar Labs and Enterprise Singapore’s Global Innovation Alliance launch international partnership

The joint program, called GIA @ Bakar Labs, gives Singaporean startups access to Bakar Labs' world class biotech, energy tech and materials engineering incubator system. Companies will also gain access to Bakar Labs' network at UC Berkeley and beyond, and its ecosystem of investors, legal and business support throughout the Bay Area.

Latest news²⁹¹

Bakar Labs News Nov 2, 2026

Five years at Bakar Labs: Highlighting five innovative companies making a difference

To celebrate our fifth anniversary, we're highlighting five notable companies — tenants and alumni of Bakar Labs doing amazing things at the intersection of science, innovation, and entrepreneurship. First up: Arcadia Science. Read post

Company News Oct 27, 2026

HexemBio Chooses Stem Cell Transplantation as Its First Longevity Clinical Target

KOREA TECH DESK — The U.S. biotech is pursuing stem cell transplantation, where its broader longevity hypothesis can be tested against established medical outcomes. Read post

Bakar Labs News Oct 20, 2026

When everyone shares the lab, who owns the risk?

LAB MANAGER – Shared facilities need clear safety responsibilities, risk-based training, controlled access, and escalation paths that work when supervisors are absent Read post

Company News Oct 9, 2026

Agilent customer story: Rocío Sampayo, Axent Biosciences

AGILENT - Learn how Axent Biosciences is advancing manufacturing solutions to expand access to cell therapies. Read post

Man in white t-shirt works at automated cell culture system on benchtop. Other person in dark top in background

Tenant Spotlight Oct 8, 2026

AI was inspired by the brain. Open Culture is turning it into a tool for neuroscience.

Spencer Seiler spent years building tiny automated laboratories capable of growing and studying millions of human neurons. Now, he’s pairing that technology with AI—and with help from QB3, turning years of academic research into a neuroscience tools company. Read post

Smiling man in vest at table talks to woman with long hair and backpack at a table in a crowded courtyard

Tenant Spotlight Oct 6, 2026

Getting ahead of lung disease: Voyra Therapeutics targets pulmonary fibrosis

Rather than waiting until irreversible damage has occurred in progressive lung disease, Voyra Therapeutics is developing therapies designed to protect tissue and promote its natural regeneration. Now, with promising results in human IPF lung tissue and mouse models, the company is raising capital to move its approach closer to the clinic. Read post

Company News Oct 6, 2026

Azalea VP of Corporate Strategy Anastasiia Kamenska named to Biospace 2026 40 Under 40

The prestigious list honors exemplary biotech and pharma professionals who have distinguished themselves in their companies and their field. The young leaders demonstrate innovation, business impact and commitment to improving outcomes for patients. Read post

Company News Oct 5, 2026

Lento Bio to Present Updates on LB-01, its Lens Flexibility Restoring Eye Drop for Presbyopia, at Eyecelerator 2026

COURIER JOURNAL – “LB-01 is designed to restore the lens’s natural flexibility and would be the first rejuvenating therapy that acts as disease modifying rather than symptomatic,” CEO Kris Barnes told the Courier Journal. Read post

Company News Oct 2, 2026

HOPO Therapeutics named 5th highest-funded MBA-founded startup of 2026

POETS & QUANTS – The company, co-founded by Haas MBA/MPH graduate Hannah Weber, is “developing the first oral treatments for heavy-metal poisoning and radiological exposure.” Read post

Company News Oct 2, 2026

HexemBio looks beyond capital as KIP opens a door to Korea’s biotech network

KOREA TECH DESK – HexemBio, a U.S. preclinical biotech developing therapies designed to rejuvenate aging blood stem cells, announced a USD 10.4 million seed round led by Draper Associates in April 2026. By September, the company said its total funding had reached USD 15.5 million, with Korea Investment Partners investing USD 2 million through the KIPUS Trinitas Fund. Read post

Company News Oct 1, 2026

Profluent and BioMarin Partner to Design Novel Enzyme Therapies Using AI

HLTH – The two companies have entered a collaboration focused on designing and optimizing novel enzyme therapies for BioMarin’s pipeline, combining artificial intelligence-based protein design with the pharmaceutical company’s experience developing enzyme replacement therapies for genetically defined conditions. Read post

Press Release Sep 30, 2026

Ray Therapeutics Awarded $8 Million CIRM Grant to Advance RTx-021 Gene Therapy for Stargardt Disease

PRESS RELEASE - The grant will help the company advance RTx-021 for the treatment of Stargardt disease. Read post

Company News Sep 30, 2026

QUiCKR Bio collaborating with INTEGRA to streamline CRISPR workflows

NEWS-MEDICAL.NET – The collaboration aims to create efficient automated solutions that take advantage of the ASSIST PLUS pipetting robot, VOYAGER adjustable tip spacing pipette, VIAFLO electronic pipette and MINI 96 portable electronic pipette. Read post

Company News Sep 30, 2026

Ray Therapeutics Awarded $8 Million CIRM Grant to Advance RTx-021 Gene Therapy for Stargardt Disease

Ray Therapeutics (RayTx), an industry-leading clinical-stage biopharmaceutical company pioneering differentiated vision restoration therapies for those living with severe retinal degenerations, today announced it has been awarded an $8 million grant from the California Institute for Regenerative Medicine (CIRM) to advance RTx-021 for the treatment of Stargardt disease. The funding will support the ongoing Phase 1/2 clinical trial and manufacturing activities to prepare the program for late-stage development. Read post

Woman in black watches man in lab coat load sample into equipment

Affiliate News Sep 28, 2026

How Agilent helps our startups move faster

Agilent Technologies takes viewers inside Bakar Bio Labs in a new video highlighting how its instruments power discovery for our resident companies. Through the partnership, Agilent places and maintains equipment in our shared core facilities, trains scientists, and offers office hours for troubleshooting. Startups featured in the video — FutureBio, Axent Biosciences, and Transition Metal Solutions — use HPLC and LC-MS to verify compounds, the Cytation 5 to automate cell imaging, and ICP for precise trace measurements. By taking instrumentation off founders' plates, the partnership frees up time and capital so teams can focus on the science! Read post

Company News Sep 25, 2026

Azalea Therapeutics named one of biotech’s most exciting startups of 2026 on the Endpoints 11 list

ENDPOINTS — Endpoints "received more than 150 nominations — from industry leaders, marquee investors and at least one Nobel Prize winner — and sourced many more companies on our own. Since late spring, Endpoints News journalists have spent dozens of hours researching candidates and debating who deserved to make the cut." Read post

Decorative graphic "Endpoints 11" featuring Jenny Hamilton

Company News Sep 25, 2026

Endpoints 11: Azalea Therapeutics melds gene editing and CAR-T

Azalea Therapeutics was named to the Endpoints 11, "biotech's most exciting startups of 2026. Read the full story at Endpoints News (paywall). Read post

Bakar Bio Labs News Sep 24, 2026

Founders and funders connect at this year’s Bakar Bio Labs company showcase

The annual networking event brought together high-caliber investors with high quality startups, catalyzing deals and innovation Read post

Latest news291

Latest news²⁹¹